The multiple effects of thyroid disorders on bone and mineral metabolism;Os múltiplos efeitos das disfunções tireoidianas sobre o metabolismo osteomineral

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 58, Issue 5, 2014, Pages 452-463

  Cardoso, Ludmilla F ^a   Maciel, Léa M Z ^a   de Paula, Francisco J A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hypothyroidism; Osteoporosis; Thyroid hormone resistance; Thyroid hormones; Thyrotoxicosis

Indexed keywords

CALCIUM; LIOTHYRONINE; MINERAL; PHOSPHORUS; THYROXINE;

ANIMAL; BIBLIOGRAPHIC DATABASE; BONE; BONE MINERALIZATION; COMPLICATION; EPIPHYSIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPOTHYROIDISM; METABOLISM; OSTEOCLAST; OSTEOPOROSIS; PHYSIOLOGY; THYROID DISEASE; THYROID HORMONE RESISTANCE; THYROTOXICOSIS;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; DATABASES, BIBLIOGRAPHIC; EPIPHYSES; HUMANS; HYPOTHYROIDISM; MINERALS; OSTEOCLASTS; OSTEOPOROSIS; PHOSPHORUS; THYROID DISEASES; THYROID HORMONE RESISTANCE SYNDROME; THYROTOXICOSIS; THYROXINE; TRIIODOTHYRONINE;

EID: 84906684052     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/0004-2730000003311     Document Type: Review

References (70)

1. Williams GR, Harvey CB. Mechanism of thyroid hormone action. Thyroid. 2002;12(6):441-6.
2. Kinne A, Schülein R, Krause G. Primary and secondary thyroid hormone transporters. Thyroid Res. 2011;3(4)Suppl 1:S7.
3. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev. 1993;14:184-93.
4. Capelo L P, Beber EH, Fonseca TL, Gouveia CH. The monocarbo-xylate transporter 8 and L-type amino acid transporters 1 and 2 are expressed in mouse skeletons and in osteoblastic MC3T3-E1 cells. Thyroid. 2009;19:171-80.
5. Bassett JH, Williams GR. The skeletal phenotypes of TRalpha and TRbeta mutant mice. J Mol Endocrinol. 2009;42:269-82.
6. Abe E, Marians RC, Yu W, Hu XB, Ando T, Li Y, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003;115(2):151-62.
7. Nicholls JJ, Brassill NJ, Williams GR, Bassett JHD. The skeletal consequences of thyrotoxicosis. J Endocrinol. 2012;213:209-21.
8. Gouveia CH. O efeito molecular e estrutural do hormônio tireoi-diano no esqueleto. Arq Bras Endocrinol Metab. 2004;48/1:183-95.
9. Gu WX, Stern PH, Madison LD, Du GG. Mutual up-regulation of thyroid hormone and parathyroid hormone receptors in rat osteo-blastic osteosarcoma 17/2.8 cells. Endocrinology. 2001;142:157-64.
10. Gruber R, Czerwenka K, Wolf F, Ho GM, Willheim M, Peterlik M. Expression of vitamin D receptor, of estrogen and thyroid hormone receptor alpha- and beta-isoforms, and the androgen receptor in cultures of native mouse bone marrow and of stromal/osteo-blastic cells. Bone. 1999;24:465-73.
11. Freitas FR, Moriscot AS, Jorgetti V, Soares AG, Passarelli M, Scanlan TS, et al. Spared bone mass in rats treated with thyroid hormone receptor TRβ-selective compound GC-1. Am J Physiol Endocrinol. 2003;285:E1135-41.
12. O'Shea PJ, Basset JHD, Sriskantharajah S, Ying H, Cheng S, Williams GR. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 ou beta. Mol Endocrinol. 2005;19(12):3045-59.
13. Varga F, Rumpler M, Klaushofer K. Thyroid hormone increase insulin-like growth factor mNRA levels in the clonal osteoblastic cell line MC3T3-E1. FEBS Lett. 1994;345:67-70.
14. Gouveia CH, Christoffolete MA, Zaitune CR, Dora JM, Harney JW, Maia AL, et al. Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology. 2005;146:195-200.
15. Gallford TM, Murphy E, Williams AJ, Basset JHD, Williams GR. Effects of thyroid status on bone metabolism: a primary role for thyroid stimulating hormone or thyroid hormone. Minerva Endo-crinol. 2005;30:237-46.
16. Ma R, Morshed S, Latif R, Zaidi M, Davies TF. The infuence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis. Thyroid. 2011;21(8):897-906.
17. Bachrach LK. Skeletal development in childhood and adolescence. In: Rosen C (ed.). Primer on the metabolic bone diseases and disorders of mineral metabolism. Seventh Edition. An offcial publication of The American Society for Bone and Mineral Research. 2008;14:74-80.
18. Alessandri SB, Pereira Fde A, Villela RA, Antonini SR, Elias PC, Martinelli CE Jr, et al. Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist. Clinics (Sao Paulo). 2012;67(6):591-6.
19. Gois MB Jr, Salvatori R, Aguiar-Oliveira MH, Pereira FA, Oliveira CR, Oliveira-Neto LA, et al. The consequences of growth hormone-releasing hormone receptor haploinsuffciency for bone quality and insulin resistance. Clin Endocrinol (Oxf). 2012;77(3):379-84.
20. Lanna CM, Paula FJ, Montenegro RM Jr, Moreira AC, Foss MC. Parathyroid hormone secretion in chronic human endogenous hypercortisolism. Braz J Med Biol Res. 2002;35(2):229-36.
21. Lanna CM, Paula FJ, Montenegro RM Jr. Fisiopatologia da osteo-porose induzida por glicocorticóide. Arq Bras Endocrinol Metab. 2003;47(1):9-18.
22. Waung JA, Bassett JHD, Williams GR. Thyroid hormone metabolism in skeletal development and adult bone maintenance. Trends Endocrinol Metab. 2011;23(4):155-62.
23. Boersma B, Otten BJ, Stoelinga GB, Wit JM. Catch-up growth after prolonged hypothyroidism. Eur J Pediatr. 1996;155:362-7.
24. Segni M, Gorman CA. The aftermath of childhood hyperthyroi-dism. J Pediatr Endocrinol Metab. 2001;14:1277-82.
25. Williams GR, Bland R, Sheppard MC. Characterization if thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology. 1994;136:4304-14.
26. Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology. 2000;141:3887-97.
27. Katz H P, Youlton R, Kaplan SL, Grumbach MM. Growth and growth hormone release in children with primary hypothyroidism and thyrotoxicosis. J Clin Endocrinol Metab. 1969;29:346-8.
28. Chernausek SD, Turner R. Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor-I concentration. J Pediatr. 1989;114:968-72.
29. Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Ra-janayagam O, Keogh JM, et al. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med. 2012;366(3):243-9.
30. Moran C, Schoenmakers N, Agostini M, Schoenmakers E, Offah A, Kydd A, et al. An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha. J Clin Endocrinol Metab. 2013;98(11):4254-61.
31. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med. 1995;123(8):572-83.
32. Weiss RE, Refetoff S. Effect of thyroid hormone on growth. Lessons from the syndrome of resistance to thyroid hormone. Endo-crinol Metab Clin North Am. 1996;25(3):719-30.
33. Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter, and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab. 1967;27:279-294.
34. Dumitrescu AM, Refetoff S. The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta. 2013;1830(7):3987-4003.
35. Cardoso L F, de Paula FJA, Maciel LMZ. Evaluation of bone and mineral metabolism in patients with the syndrome of resistance to thyroid hormone. XV Latin American Thryoid Congress LATS. Florianópolis, Brazil, March 20-23/2013:130.
36. Mundy GRaCD, Oyajobi BO. Bone remodeling. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research. 2003. p. 28-31.
37. Bassett JH, Boyde A, Howell PG, Bassett RH, Galliford TM, Archanco M, et al. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci USA. 2010;107(16):7604-9.
38. Vestergaard P, Bassett L. Fractures in patients with hyperthyroi-dism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002;12:411-19.
39. Gorka J, Taylor-Gjevre RM, Arnason T. Metabolic and clinical consequences of hyperthyroidism on bone density. Int J Endocrinol. 2013;2013:638727. doi: 10.1155/2013/638727. Epub 2013 Jul 22.
40. Allain TJ, Thomas MR, McGregor AM, Salisbury JR. A histomor-phometric study of bone changes in thyroid dysfunction in rats. Bone. 1995;16:505-9.
41. Mosekilde L, Melsen F, Christensen MS. Interrelationships between bone morphometry, thyroid function tests and serum parathyroid hormone in hyperthyroidism. Calcif Tissue Res. 1977;22:229-35.
42. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral and fracture risk - a meta-analysis. Thyroid. 2003;13:585-93.
43. Johnson KR, Marden CC, Ward-Bailey P, Gagnon LH, Bronson RT, Donahue LR. Congenital hypothyroidism, dwarfsm, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol Endocrinol. 2007;21:1593-602.
44. Gouveia CH, Jorgetti V, Bianco AC. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats. J Bone Miner Res. 1997;12:2098-107.
45. Suwanwalaikorn S, Ongphiphadhanakul B, Braverman LE, Baran DT. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats. Eur J En-docrinol. 1996;134:655-9.
46. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocrine Reviews. 2010;31(5):702-55.
47. Buzzard JJ, Morrison JR, O'Bryan MK, Song Q, Wreford NG. Developmental expression of thyroid hormone receptors in the rat testis. Biol Reprod. 2000;62:664-9.
48. Zhang SS, Carrillo AJ, Darling DS. Expression of multiple thyroid hormone receptor mRNAs in human oocytes, cumulus cells, and granulosa cells. Mol Hum Reprod. 1997;3(7):555-62.
49. de Lima, Nobrega LHC, de Mendonça RP. Introdução ao meta-bolismo ósseo e mineral. In: Bandeira F, Graf H, Griz L, Faria M, Lazaretti-Castro M (eds.) Endocrinologia e Diabetes, 2.ed., Rio de Janeiro: Medbook - Editora Científca Ltda. 2009;363-368.
50. Persons V, Anderson J. The maximum renal tubular reabsor-tive rate for inorganic phosphate in thyrotoxicosis. Cli Sci. 1964;27:313-8.
51. Espinosa RE, Keller MJ, Yusuf ANK, Dousa TP. Effect of thyroxine administration on phosphate transport across renal cortical brush border membrane. Am J Physiol. 1984;246(15):F133-9.
52. Euzet S, Lelievre-Pegorier M, Merlet-Benichou C. Maturation of rat renal phosphate transport: effects of triiodothyronine. J Physiol. 1995;488(Pt 2):449-57.
53. Mosekilde L, Eriksen E F, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 1990;19(1):35-63.
54. Pantazi H, Papapetrou PD. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab. 2000;85(3):1099-106.
55. Veríssimo JMT, de Oliveira HL, Mazzoncini M, Lomonaco DA. Estudo do metabolismo do cálcio na tireotoxicose humana. Rev Assoc Med Brasil. 1965;11:11-23.
56. Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, et al. Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab. 2005;90(7):4211-5.
57. Langdahl BL, Loft AGR, Eriksen E F, Mokesilde L, Charles P. Bone mass, bone turnover and body composition in former hypo-thyroid patients receiving replacement therapy. Eur J Endocrinol. 1996;134:702-9.
58. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, et al. Persistent increase in bone turnover in Graves' patients with sub-clinical hyperthyroidism. J Clin Endocrinol Metab. 2000;85:4157-61.
59. Marcocci G, Golia F, Vignali E, Pinchera A. A skeletal integrity in men chronically treated with suppressive doses of thyroxine. J Bone Miner Res. 1997;12:72-7.
60. Dare GLR, Magalhães PKR, Castro M, Maciel LMZ. Peripheral parameters of thyroid hormone action in resistance to thyroid hormone syndrome: a focus on mineral metabolism. Thyroid. 2009;19(7):785-7.
61. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet. 1998;19:87-90.
62. Friedrichsen S, Christ S, Heuer H, Schafer MK, Mansouri A, Bauer K, et al. Regulation of iodothyronine deiodinases in the Pax8- /- mouse model of congenital hypothyroidism. Endocrinology. 2003;144:777-84.
63. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA. 2002;99:15776-81.
64. Beamer WG, Cresswell LA. Defective thyroid ontogenesis in fetal hypothyroid (hyt/hyt) mice. Anat Rec. 1982;202:387-93.
65. Gu WX, Du GG, Kopp P, Rentoumis A, Albanese C, Kohn LD, et al. The thyrotropin (TSH) receptor transmembran domain mutation (Pro556--Leu) in the hypothyroid hyt/hyt mouse models in plasma membrane targeting but defective TSH biding. Endocrinology. 1995;136:3146-53.
66. Fraichard A, Chassande O, Plateroti M, Roux J P, Trouillas J, Dehay C, et al. The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J. 1997;16:4412-20.
67. Gauthier K, Chassande O, Plateroti M, Roux J P, Legrand C, Rousset B, et al. Different functions for the thyroid hormones receptors TRα and TRβ in the control of thyroid hormone production and post-natal development. Embo J. 1999;18:623-31.
68. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C, et al. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfsm in mice. Proc Natl Acad Sci U S A. 2001;98(26):15095-100.
69. Forrest D, Sjoberg M, Vennstrom B. Contrasting developmental and tissue-specifc expression of alpha and beta thyroid hormone receptor genes. EMBO J. 1990;9:1519-28.
70. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, et al. Mice with a targeted mutation in the thyroid hormone beta-receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA. 2000;97:13209-14.